 |
 |
I was in the trial in 1998-1999 for six months, but not for "off." This drug is much like selegiline, Eldepryl. Charlotte Mancuso Linda J Herman wrote: > I received the following message from CenterWatch about clinical trials > in many locations for rasagiline. SEE summary of the study below and the > forwarded message. Is anyone already participating in a trial of this > drug? > Linda > > "Trial Information > > Summary: PRESTO (Parkinson's Rasagiline: Efficacy & Safety in the > Treatment of "OFF") > The Parkinson Study Group (PSG), in collaboration with Teva > Neurosciences, Inc., is conducting a study for patients with moderate to > advanced Parkinson's Disease. This 26-week study will examine the safety, > effectiveness and tolerability of an investigational drug in patients who > do not experience full benefit from their L-dopa dosage. > > The study plans to recruit 450 subjects at 59 sites across the United > States and Canada. Enrollment began in September 2000. For more details, > contact one of the participating sites near you." > <http://www.centerwatch.com/patient/studies/stu30215.html> > > --------- Forwarded message ---------- > From: CenterWatch Patient Notification Service <[log in to unmask]> > Date: Sat Nov 3 06:42:19 2001 > > New clinical trials recently posted on the CenterWatch web site at > http://www.centerwatch.com. > > 1) PRESTO (Parkinson's Rasagiline: Efficacy & Safety in the Treatment of > "OFF"). This study is being conducted in: > - Toledo, OH > (http://www.centerwatch.com/patient/studies/stu30219.html) > - St. Louis, MO > (http://www.centerwatch.com/patient/studies/stu30204.html) > - Tampa, FL > (http://www.centerwatch.com/patient/studies/stu30191.html) > - Temple, TX > (http://www.centerwatch.com/patient/studies/stu30223.html) > - Rochester, NY > (http://www.centerwatch.com/patient/studies/stu30215.html) > - San Francisco, CA > (http://www.centerwatch.com/patient/studies/stu30177.html) > - Southfield, MI > (http://www.centerwatch.com/patient/studies/stu30202.html) > - Philadelphia, PA > (http://www.centerwatch.com/patient/studies/stu30220.html) > - Phoenix, AZ > (http://www.centerwatch.com/patient/studies/stu30171.html) > - Richmond, VA > (http://www.centerwatch.com/patient/studies/stu30226.html) > - Omaha, NE > (http://www.centerwatch.com/patient/studies/stu30205.html) > - Oxnard, CA > (http://www.centerwatch.com/patient/studies/stu30176.html) > - Pawtucket, RI > (http://www.centerwatch.com/patient/studies/stu30222.html) > - New York, NY > (http://www.centerwatch.com/patient/studies/stu30212.html) > - New York, NY > (http://www.centerwatch.com/patient/studies/stu30213.html) > - New York, NY > (http://www.centerwatch.com/patient/studies/stu30214.html) > - New Haven, CT > (http://www.centerwatch.com/patient/studies/stu30188.html) > - New Hyde Park, NY > (http://www.centerwatch.com/patient/studies/stu30211.html) > - New Orleans, LA > (http://www.centerwatch.com/patient/studies/stu30198.html) > - Miami, FL > (http://www.centerwatch.com/patient/studies/stu30190.html) > - Minneapolis, MN > (http://www.centerwatch.com/patient/studies/stu30203.html) > - New Brunswick, NJ > (http://www.centerwatch.com/patient/studies/stu30206.html) > - Little Rock, AR > (http://www.centerwatch.com/patient/studies/stu30170.html) > - Los Angeles, CA > (http://www.centerwatch.com/patient/studies/stu30175.html) > - Manhasset, NY > (http://www.centerwatch.com/patient/studies/stu30210.html) > - Irvine, CA > (http://www.centerwatch.com/patient/studies/stu30174.html) > - Jacksonville, FL > (http://www.centerwatch.com/patient/studies/stu30189.html) > - Kansas City, KS > (http://www.centerwatch.com/patient/studies/stu30197.html) > - Houston, TX > (http://www.centerwatch.com/patient/studies/stu30224.html) > - Indianapolis, IN > (http://www.centerwatch.com/patient/studies/stu30196.html) > - Iowa City, IA > (http://www.centerwatch.com/patient/studies/stu30194.html) > - Farmington, CT > (http://www.centerwatch.com/patient/studies/stu30187.html) > - Fountain Valley, CA > (http://www.centerwatch.com/patient/studies/stu30172.html) > - Fresno, CA > (http://www.centerwatch.com/patient/studies/stu30173.html) > - Cleveland, OH > (http://www.centerwatch.com/patient/studies/stu30218.html) > - Denver, CO > (http://www.centerwatch.com/patient/studies/stu30185.html) > - Denver, CO > (http://www.centerwatch.com/patient/studies/stu30186.html) > - Chicago, IL > (http://www.centerwatch.com/patient/studies/stu30195.html) > - Cincinnati, OH > (http://www.centerwatch.com/patient/studies/stu30216.html) > - Cleveland, OH > (http://www.centerwatch.com/patient/studies/stu30217.html) > - Boston, MA > (http://www.centerwatch.com/patient/studies/stu30199.html) > - Boston, MA > (http://www.centerwatch.com/patient/studies/stu30200.html) > - Charlottesville, VA > (http://www.centerwatch.com/patient/studies/stu30225.html) > - Augusta, GA > (http://www.centerwatch.com/patient/studies/stu30193.html) > - Baltimore, MD > (http://www.centerwatch.com/patient/studies/stu30201.html) > - Birmingham, AL > (http://www.centerwatch.com/patient/studies/stu30169.html) > - Albany, NY > (http://www.centerwatch.com/patient/studies/stu30208.html) > - Albequerque, NM > (http://www.centerwatch.com/patient/studies/stu30207.html) > - Atlanta, GA > (http://www.centerwatch.com/patient/studies/stu30192.html) > > In addition to the CenterWatch patient notification service, through a > collaboration with The HealthExchange, patients can also be actively > matched to select clinical trials. Visit > http://www.centerwatch.com/thehealthexchange.html to learn more about the > HealthExchange Clinical Trials Matching Service. > > --------------------------------------------------------- > > CenterWatch offers other publications and services that you can use to > learn about clinical trials for your medical condition. We publish a > series of reports that focus on specific illnesses. Each report provides > information about clinical trials results, drugs in development and > ongoing clinical studies. Visit > http://www.centerwatch.com/bookstore/pubs_cons_nmtform.html to see if > there is a report for you. > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn